LEXISCAN(R) (REGADENOSON)

Product NDC
51662-1448
11-digit product format
516621448
Labeler code
51662
Product ID
51662-1448_0ffbfae4-66b6-b616-e063-6294a90a2d06
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
LEXISCAN(R) (REGADENOSON)
Dosage form
INJECTION, SOLUTION
Route
INTRAVENOUS
Labeler
HF Acquisition Co LLC, DBA HealthFirst
Application
NDA022161
Marketing category
NDA
Marketing start
2019-12-10
Substance
REGADENOSON
Active strength
.08 mg/mL
Pharmacologic classes
Adenosine Receptor Agonists [MoA], Pharmacologic Cardiac Stress Test Agent [EPC]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Additional Listing Data#

Finished product
Yes
Brand name base
LEXISCAN(R) (REGADENOSON)
Listing expiration
2026-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
REGADENOSON.08 mg/mL

Harmonized Identifiers#

Field, Values table
FieldValues
Unii2XLN4Y044H

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
60758f30-9b07-ad4c-2eb4-c357ebb784a4Product name520250317

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
51662-1448-1LEXISCAN(R) (REGADENOSON)5 mL in 1 SYRINGE, PLASTICINJECTION, SOLUTION54
51662-1448-1LEXISCAN(R) (REGADENOSON)1 in 1 CARTONINJECTION, SOLUTION14

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
51662-1448LEXISCAN(R) (REGADENOSON) INJECTION, SOLUTION [HF ACQUISITION CO LLC, DBA HEALTHFIRST]4Current NDC, Legacy NDC, 2 package rows20240129_99640071-4db2-9317-e053-2995a90a610d.zip

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startMarketing endSampleExclude flagStatus
51662-1448-1516621448011 SYRINGE, PLASTIC in 1 CARTON (51662-1448-1) / 5 mL in 1 SYRINGE, PLASTIC2019-12-100000-00-00NoNoCurrent